{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:26:19Z","timestamp":1784582779400,"version":"3.55.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.patbio.2006.06.002","type":"journal-article","created":{"date-parts":[[2006,8,22]],"date-time":"2006-08-22T12:03:03Z","timestamp":1156248183000},"page":"92-104","source":"Crossref","is-referenced-by-count":24,"title":["Current diagnostic criteria for\u00a0the\u00a0chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and\u00a0chronic idiopathic myelofibrosis (CIMF)"],"prefix":"10.1016","volume":"55","author":[{"given":"J.J.","family":"Michiels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Bernema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Van Bockstaele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"De Raeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Schroyens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.patbio.2006.06.002_bib1","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/jama.1950.02910290018005","article-title":"Physiopathology and course of polycythemia vera as related to therapy","volume":"142","author":"Dameshek","year":"1950","journal-title":"J Am Ass Med"},{"key":"10.1016\/j.patbio.2006.06.002_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2005.10.003","article-title":"JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects","author":"James","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.patbio.2006.06.002_bib3","first-page":"343","article-title":"Polycthemia vera, its course and treatment: relation to myeloid metaplasia and leukemia","volume":"30","author":"Wasserman","year":"1954","journal-title":"Bull. N. Y. Acad. Med."},{"key":"10.1016\/j.patbio.2006.06.002_bib4","series-title":"Berlin NI. Polycythemia vera and the myeloproliferative disorders","author":"Wasserman","year":"1995"},{"key":"10.1016\/j.patbio.2006.06.002_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2257.1979.tb00467.x","article-title":"The course and complications of idiopathic erythrocytosis","volume":"1","author":"Pearson","year":"1979","journal-title":"Clin. Lab. Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajh.2830100204","article-title":"Pure erythrocytosis: reappraisal of a study of 51 patients","volume":"10","author":"Najean","year":"1981","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7326\/0003-4819-71-2-285","article-title":"Transitions among the myeloproliferative disorders","volume":"71","author":"Glaser","year":"1969","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.patbio.2006.06.002_bib8","doi-asserted-by":"crossref","unstructured":"Burkhardt R., Bartl R., Jaeger K., Frisch B., Kettner G., Mahl G., Sund M. Chronic myeloproliferative disorders. Path Res Pract 1084;179:131-186.","DOI":"10.1016\/S0344-0338(84)80124-7"},{"key":"10.1016\/j.patbio.2006.06.002_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00430654","article-title":"Chronic megakaryocytic granulocytic myelosis: CMGM","volume":"389","author":"Georgii","year":"1980","journal-title":"Virch Arch A Path Anat Histol"},{"key":"10.1016\/j.patbio.2006.06.002_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0344-0338(11)81008-3","article-title":"Chronic myeloproliferative disorders in bone marrow biopsies","volume":"186","author":"Georgii","year":"1990","journal-title":"Path Res Pract"},{"issue":"Suppl 1","key":"10.1016\/j.patbio.2006.06.002_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/10428199609074357","article-title":"Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies","volume":"22","author":"Georgii","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.patbio.2006.06.002_bib12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0950-3536(98)80036-X","article-title":"The histopathology of chronic myeloproliferative diseases","volume":"11","author":"Georgii","year":"1998","journal-title":"Baili\u00e8re\u2019s Clin Haematol"},{"key":"10.1016\/j.patbio.2006.06.002_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00432237","article-title":"Chronic megakaryocytic granulocytic myelosis: An electron microscopic study. Megakaryocytes and thrombocytes","volume":"373","author":"Thiele","year":"1977","journal-title":"Virch Arch"},{"key":"10.1016\/j.patbio.2006.06.002_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0609.1983.tb00661.x","article-title":"Density distribution and size of megakaryocytes in inflammatory reactions of the bone marrow (myelitis) and chronic myeloproliferative disorders","volume":"31","author":"Thiele","year":"1983","journal-title":"Scand. J. Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib15","first-page":"375","article-title":"Primary (essential) thrombocythemia versus polycythemia vera rubra. A histomorphometric analysis of bone marrow features in trephine biopsies","volume":"10","author":"Thiele","year":"1988","journal-title":"Analyt Quat Cytol Histol"},{"key":"10.1016\/j.patbio.2006.06.002_bib16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000205560","article-title":"Primary (essential) thrombocythemia versus hyperplastic stages of agnogenic myeloid metaplasia with thrombocytosis: a critical evaluation of clinical and histomorphological data","volume":"81","author":"Thiele","year":"1989","journal-title":"Acta Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02890084","article-title":"Megakaryocyte precursors (pro- and megakaryoblasts) in bone marrow tissue from patients with reactive thrombocytosis, polycythemia vera and primary (essential) thrombocythemia","volume":"58","author":"Thiele","year":"1990","journal-title":"Virch Arch"},{"key":"10.1016\/j.patbio.2006.06.002_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/10428199609051762","article-title":"Idiopathic primary osteo-myelofibrosis: A clinico-pathological study on 208 patients wit special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact","volume":"22","author":"Thiele","year":"1996","journal-title":"Leuk. Lymphoma"},{"issue":"Suppl 1","key":"10.1016\/j.patbio.2006.06.002_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428199609074356","article-title":"The myeloproliferative disorders. An historical appraisal and personal experiences","volume":"22","author":"Michiels","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.patbio.2006.06.002_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0300-2977(97)00018-1","article-title":"Diagnostic criteria of the myeloproliferative disorders (MPD) essential thrombocythemia, polycythemia vera and chronic megakaryocytic granulocytic metaplasia","volume":"51","author":"Michiels","year":"1997","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.patbio.2006.06.002_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2007-996107","article-title":"Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group","volume":"23","author":"Michiels","year":"1997","journal-title":"Semin Thromb Hemostas"},{"key":"10.1016\/j.patbio.2006.06.002_bib22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s002770050546","article-title":"Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders: aids to diagnosis and classification","volume":"78","author":"Thiele","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1016\/j.patbio.2006.06.002_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/10428199909058421","article-title":"Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies","volume":"33","author":"Thiele","year":"1999","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.patbio.2006.06.002_bib24","series-title":"WHO classification of the chronic myeloproliferative diseases (CMPD) polycythemia vera, chronic idiopathic myelofibrosis, essential thrombocythemia and CMPD unclassifiable. WHO Classification of Tumours. Tumours of Haemtopoiesis and Lymphoid Tissues","first-page":"31","year":"2001"},{"key":"10.1016\/j.patbio.2006.06.002_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02982575","article-title":"Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera and idiopathic myelofibrosis (agnogenic myeloid metaplasia)","volume":"76","author":"Michiels","year":"2002","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.thj.6200368","article-title":"Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic myeloid metaplasia","volume":"5","author":"Michiels","year":"2004","journal-title":"Hematol. J."},{"key":"10.1016\/j.patbio.2006.06.002_bib27","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/sj.leu.2401553","article-title":"Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF): a clinicopathological study","volume":"13","author":"Thiele","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.patbio.2006.06.002_bib28","first-page":"1126","article-title":"Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis","volume":"85","author":"Thiele","year":"2000","journal-title":"Haematlogica"},{"key":"10.1016\/j.patbio.2006.06.002_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s002770000278","article-title":"Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis","volume":"80","author":"Thiele","year":"2001","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib30","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1080\/10428190290021542","article-title":"Early stage idiopathic (primary) myelofibrosis: current issues of diagnostic features","volume":"43","author":"Thiele","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.patbio.2006.06.002_bib31","first-page":"93","article-title":"Diagnostic differentiation of essential thrombocythemia from thrombocythemia associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features","volume":"18","author":"Thiele","year":"2003","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.patbio.2006.06.002_bib32","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/1042819031000077070","article-title":"Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: a follow-up on 308 patients","volume":"44","author":"Thiele","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.patbio.2006.06.002_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00277-002-0604-y","article-title":"Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classifications systems (PVSG-WHO) on 839 patients","volume":"82","author":"Thiele","year":"2003","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000076524","article-title":"Prefibrotic chronic myelofibrosis \u2013 a diagnostic enigma?","volume":"111","author":"Thiele","year":"2004","journal-title":"Acta Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib35","first-page":"633","article-title":"Standadization of bone marrow features\u2014does it work in hematopathology for histological discrimination of different disease patterns?","volume":"20","author":"Thiele","year":"2005","journal-title":"Histopathol"},{"key":"10.1016\/j.patbio.2006.06.002_bib36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/j.seminhematol.2005.05.020","article-title":"Bone marrow histopathology in myeloproliferative disorders\u2014current diagnostic approacj","volume":"42","author":"Thiele","year":"2005","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib37","first-page":"409","article-title":"Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD and hemorrhagic thrombocythemia","volume":"12","author":"Laszlo","year":"1975","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib38","first-page":"177","article-title":"Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group","volume":"23","author":"Murphy","year":"1986","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib39","first-page":"339","article-title":"Diagnosis and classification of the polycythemias","volume":"12","author":"Berlin","year":"1975","journal-title":"Sem Hematol"},{"key":"10.1016\/j.patbio.2006.06.002_bib40","first-page":"368","article-title":"The value of bone marrow histopathology for the differentiation between early stage polycythemia vera and secondary (reactive) polycythemias","volume":"86","author":"Thiele","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.patbio.2006.06.002_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1078\/0344-0338-5710013","article-title":"Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients","volume":"197","author":"Thiele","year":"2001","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.patbio.2006.06.002_bib42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00277-005-1030-8","article-title":"Bone marrow features of diagnostic impact in erythrocytosis","volume":"84","author":"Thiele","year":"2005","journal-title":"Ann Haematol"},{"key":"10.1016\/j.patbio.2006.06.002_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000084673","article-title":"Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia","volume":"113","author":"Thiele","year":"2005","journal-title":"Acta Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib44","first-page":"317","article-title":"Diagnostic impact of bone marrow histopathology in polycythemia vera (PV)","volume":"20","author":"Thiele","year":"2005","journal-title":"Histol Histpathol"},{"key":"10.1016\/j.patbio.2006.06.002_bib45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4065\/78.2.174","article-title":"Polycythemia vera: a comprehensive review and clinical recommendations","volume":"78","author":"Tefferi","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.patbio.2006.06.002_bib46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2141.2005.05535.x","article-title":"Guidelines for the diagnosis, investigation and management of polycythaemia\/erythrocytosis","volume":"130","author":"McMullin","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2007-996117","article-title":"Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in Budd-Chiari syndrome or portal vein thrombosis","volume":"23","author":"De Stefano","year":"1997","journal-title":"Semin Thromb Hemostas"},{"key":"10.1016\/j.patbio.2006.06.002_bib48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2141.2005.05490.x","article-title":"Relevance of the criteria commonly used to diagnose myeloproliferative disorders in patients with splanchnic vein thrombosis","volume":"129","author":"Chait","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib49","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1182\/blood-2002-07-2287","article-title":"Discrimination of polycythemias and thrombocythemias by novel, simple accurate clonality assays and comparison with PRV-1 expression and BFU:E response to erythropoietin","volume":"101","author":"Liu","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2006.06.002_bib50","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1182\/blood.V83.3.744.744","article-title":"Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay","volume":"83","author":"Shih","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2006.06.002_bib51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/10428199609074366","article-title":"Diagnostic applications of haematopoietic progenitor culture techniques in polycythaemias and thrombocythaemias","volume":"22","author":"Westwood","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.patbio.2006.06.002_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.thj.6200344","article-title":"Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia vera","volume":"5","author":"Dobo","year":"2004","journal-title":"Hematol. J."},{"key":"10.1016\/j.patbio.2006.06.002_bib53","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2003-10-3502","article-title":"Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential thrombocythemia","volume":"103","author":"Florensa","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2006.06.002_bib54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1365-2141.2002.03386.x","article-title":"Serum erythropoietin values in erythrocytosis and in primary thrombocythaemia","volume":"117","author":"Messinezy","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1056\/NEJM198607313150503","article-title":"Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis","volume":"315","author":"Cotes","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.patbio.2006.06.002_bib56","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2141.1992.tb02999.x","article-title":"Serum erythropoietin in the diagnosis of polycythemia and after phlebotomy treatment","volume":"81","author":"Birgegard","year":"1992","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib57","first-page":"217","article-title":"Low serum erythropoietin: a strong diagnostic criterion of primary polycythaemia even at normal haemoglobin levels","volume":"17","author":"Messinezy","year":"1995","journal-title":"Clin. Lab. Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib58","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1600-0609.1998.tb01040.x","article-title":"Plasma erythropoietin by high-detectability immunoradiometric assay in untreated patients with polycythemia vera and essential thrombocythemia","volume":"60","author":"Carneskog","year":"1998","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib59","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10428190009148401","article-title":"Serum erythropoietin and thrombopoietin levels in patients with essential thrombocythemia","volume":"36","author":"Griesshammer","year":"2000","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.patbio.2006.06.002_bib60","series-title":"Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis","first-page":"1194","author":"Mossuz","year":"2004"},{"key":"10.1016\/j.patbio.2006.06.002_bib61","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood.V95.8.2569","article-title":"Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is over expressed in polycythemia rubra vera","volume":"95","author":"Temerinac","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2006.06.002_bib62","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1046\/j.1432-1327.2000.01352.x","article-title":"Towards a molecular understanding of polycythemia rubra vera","volume":"267","author":"Pahl","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.patbio.2006.06.002_bib63","first-page":"470a","article-title":"Quantification of PRV-1 expression, a molecular marker for the diagnosis of polycythemia vera","volume":"98","author":"Klippel","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2006.06.002_bib64","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000064709","article-title":"Polycythaemia vera: will new markers help us answer old questions?","volume":"108","author":"Pahl","year":"2002","journal-title":"Acta Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib65","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1034\/j.1600-0609.2003.00079.x","article-title":"The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythemia","volume":"70","author":"Johanson","year":"2003","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib66","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00277-004-0864-9","article-title":"PRV-1 mRNA expression discriminates two types of essential thrombocythemia","volume":"83","author":"Griesshammer","year":"2004","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib67","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2141.1993.tb08271.x","article-title":"Megakaryocyte and erythroid colony formation in essential thrombocythemia and reactive thrombocytosis: diagnostic value and correlation to complications","volume":"83","author":"Juvonen","year":"1993","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib68","first-page":"271","article-title":"Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythemia","volume":"9","author":"Florensa","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.patbio.2006.06.002_bib69","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s002770050423","article-title":"Essential thrombocythemia at diagnosis: causes of diagnostic evaluation and presence of positive diagnostic findings","volume":"77","author":"Jantunen","year":"1998","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2141.1994.tb04969.x","article-title":"Pathogenesis of idiopathic myelofibrosis: present status and future directions","volume":"88","author":"Reilly","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib71","first-page":"327","article-title":"Agnogenic myeloid metaplasia","volume":"22","author":"Tefferi","year":"1995","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib72","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2141.1999.01262.x","article-title":"The Italian consensus conference on diagnostic criteria for myelofibrosis with myeloid metaplasia","volume":"104","author":"Barosi","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.patbio.2006.06.002_bib73","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1200\/JCO.1999.17.9.2954","article-title":"Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines","volume":"17","author":"Barosi","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.patbio.2006.06.002_bib74","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","article-title":"Myelofibrosis with myeloid metaplasia","volume":"342","author":"Tefferi","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.patbio.2006.06.002_bib75","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2169\/internalmedicine.43.540","article-title":"Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment","volume":"43","author":"Dingli","year":"2004","journal-title":"Intern. Med."},{"key":"10.1016\/j.patbio.2006.06.002_bib76","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/10428190500046554","article-title":"Bone marrow CD34+ progenitor cells in Philadelphia chromosome-negative chronic myeloproliferative disorders: a clinicopathological study on 575 patients","volume":"46","author":"Thiele","year":"2005","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.patbio.2006.06.002_bib77","first-page":"911","article-title":"Value of bone marrow biopsy in the diagnosis of essential thrombocythemia","volume":"89","author":"Florena","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.patbio.2006.06.002_bib78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ajcp\/56.1.24","article-title":"Quantification of bone marrow reticulin","volume":"56","author":"Bauermeister","year":"1971","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.patbio.2006.06.002_bib79","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/00313028209092127","article-title":"Prognostic factors in myelofibrosis","volume":"14","author":"Manoharan","year":"1982","journal-title":"Pathology"},{"key":"10.1016\/j.patbio.2006.06.002_bib80","first-page":"1128","article-title":"European consensus for grading of bone marrow fibrosis and assessment of cellularity in myeloproliferative disorders","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.patbio.2006.06.002_bib81","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0344-0338(11)80081-6","article-title":"Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes to the Hannover Classification","volume":"189","author":"Buhr","year":"1993","journal-title":"Patol Res Pract"},{"key":"10.1016\/j.patbio.2006.06.002_bib82","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ajh.10116","article-title":"Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): a retrospective clinicopathological study of 120 patients","volume":"70","author":"Thiele","year":"2002","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib83","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000083452","article-title":"The incidence of myelofibrosis in essential thrombocythemia, polycythemia vera and chronic idiopathicmyelofibrosis: a retrospective evaluation of sequential bone marrow biopsies","volume":"113","author":"Kreft","year":"2005","journal-title":"Acta Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib84","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/1042819031000077070","article-title":"Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: a follow-up study on 309 patients","volume":"44","author":"Thiele","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.patbio.2006.06.002_bib85","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1309\/PTVGB3DXB8A8M7KD","article-title":"Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens","volume":"119","author":"Buhr","year":"2003","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.patbio.2006.06.002_bib86","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/j.seminoncol.2005.04.010","article-title":"Hematopathologic findings in chronic idiopathic myelofibrosis","volume":"32","author":"Thiele","year":"2005","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.patbio.2006.06.002_bib87","series-title":"Myeloproliferative Disorders: current perspectives on diagnostic criteria, histopathology and treatment","author":"Michiels","year":"2005"},{"key":"10.1016\/j.patbio.2006.06.002_bib88","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V88.3.1013.1013","article-title":"Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a bew scoring syste","volume":"88","author":"Dupriez","year":"1996","journal-title":"Blod"},{"key":"10.1016\/j.patbio.2006.06.002_bib89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0268-960X(97)90022-9","article-title":"Idiopathic myelofibrosis: pathogenesis, natural history and management","volume":"11","author":"Reilly","year":"1997","journal-title":"Blood Rev."},{"issue":"Suppl 1","key":"10.1016\/j.patbio.2006.06.002_bib90","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/10245330512331390456","article-title":"Clinical, pathological and molecular features of myeloproliferative disorders: MPD 2005 and beyond","volume":"10","author":"Michiels","year":"2005","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/j.patbio.2006.06.002_bib91","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.patbio.2006.06.002_bib92","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cells"},{"key":"10.1016\/j.patbio.2006.06.002_bib93","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.patbio.2006.06.002_bib94","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2006.06.002_bib95","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"29","author":"Zhao","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.patbio.2006.06.002_bib96","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/blood-2005-03-1287","article-title":"On the origin of the chronic myeloproliferative disorders: it makes all sense","volume":"105","author":"Kaushanky","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2006.06.002_bib97","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMp058083","article-title":"A unifying mutation in chronic myeloproliferative disorders","volume":"352","author":"Goldman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.patbio.2006.06.002_bib98","first-page":"871","article-title":"Gain of function, loss of control. A molecular basis for chronic myeloproliferative disorders","volume":"90","author":"Cazzola","year":"2005","journal-title":"Haematologica Hematol J"},{"key":"10.1016\/j.patbio.2006.06.002_bib99","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2006.06.002_bib100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2141.2005.05764.x","article-title":"JAK2 V617 mutation in essential thrombocythaemia: clinical associations and long-term relevance","volume":"131","author":"Wolanskyj","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.patbio.2006.06.002_bib101","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/sj.leu.2403902","article-title":"Clinical implications of the JAK2 V617F mutation in essential thrombocythemia","volume":"19","author":"Antonioli","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.patbio.2006.06.002_bib102","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood-2005-04-1515","article-title":"The JAK2 V617F mutation, PRV-1 over expression and EEC formation define a similar cohort of MPD patients","volume":"106","author":"Goerttler","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2006.06.002_bib103","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1182\/blood-2005-05-1889","article-title":"Altered gene expression in myeloproliferative disorders correlates with activation of signalling by the V617F mutation of JAK2","volume":"106","author":"Kralovics","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2006.06.002_bib104","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","article-title":"The JAK2 V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia","volume":"106","author":"Levine","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2006.06.002_bib105","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","article-title":"Levine RL et al. The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both atypical myeloproliferative disorders and the myelodysplastic syndrome","volume":"106","author":"Steensma","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2006.06.002_bib106","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2005-05-1800","article-title":"JAK2 mutation 1849G >T is rare in acute leukemias but can be found in CMML, Philadelphia-chromosome negative CML and megakaryocytic leukemia","author":"Jelinek","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2006.06.002_bib107","unstructured":"Kiladjian JJ, Elkassar N, Hetet G, Balitrand N et al. Analysis of JAK2 mutation in essential thrombocythemia (ET) patients with monoclonal and polyclonal X-chromosome inactivation patterns (XCIPs). Blood (Suppl Abstract 807-II)."},{"issue":"9501","key":"10.1016\/j.patbio.2006.06.002_bib108","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(05)67785-9","article-title":"Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study","volume":"366","author":"Campbell","year":"2005","journal-title":"Lancet"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811406001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811406001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T23:42:29Z","timestamp":1587166949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811406001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":108,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0369811406001106"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2006.06.002","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}